Omeros (OMER) EBT Margin Growth (5y) (2015 - 2026)

Omeros (OMER) EBT Margin Growth (5y) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Omeros 739.31 Mn 739.31 Mn 9.31 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 76,212.00
Jun 30, 2022 40,395.00
Mar 31, 2022 -42.00
Dec 31, 2021 24,251.00
Sep 30, 2021 26,767.00
Jun 30, 2021 7,067.00
Mar 31, 2021 90,452.00
Dec 31, 2020 -52,366.00
Sep 30, 2020 130,950.00
Jun 30, 2020 268,785.00
Mar 31, 2020 3.54 Mn
Dec 31, 2019 1.17 Mn
Sep 30, 2019 2.79 Mn
Jun 30, 2019 20.43 Mn
Mar 31, 2019 5.46 Mn
Dec 31, 2018 817,348.00
Sep 30, 2018 1.61 Mn
Jun 30, 2018 828,340.00
Mar 31, 2018 -53,889.00
Dec 31, 2017 21,316.00